Global Ivosidenib Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Ivosidenib market size was valued at USD 180.4 million in 2023 and is forecast to a readjusted size of USD 247 million by 2030 with a CAGR of 4.6% during review period.
Ivosidenib is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer.
Ivosidenib's market driver is its efficacy in treating relapsed or refractory acute myeloid leukemia (AML) with IDH1 mutations. It inhibits the mutated IDH1 enzyme, leading to remission. The niche target population and limited treatment options contribute to its growth. However, challenges include potential side effects, the need for genetic testing to identify eligible patients, and competition from other AML therapies. Despite challenges, Ivosidenib's promising results and ongoing research in AML with IDH1 mutations present opportunities for market expansion.
The Global Info Research report includes an overview of the development of the Ivosidenib industry chain, the market status of Hospital (60 Tablets, 30 Tablets), Pharmacy (60 Tablets, 30 Tablets), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Ivosidenib.
Regionally, the report analyzes the Ivosidenib markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Ivosidenib market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Ivosidenib market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Ivosidenib industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., 60 Tablets, 30 Tablets).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Ivosidenib market.
Regional Analysis: The report involves examining the Ivosidenib market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Ivosidenib market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Ivosidenib:
Company Analysis: Report covers individual Ivosidenib manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Ivosidenib This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Pharmacy).
Technology Analysis: Report covers specific technologies relevant to Ivosidenib. It assesses the current state, advancements, and potential future developments in Ivosidenib areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Ivosidenib market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Ivosidenib market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Ivosidenib product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ivosidenib, with price, sales, revenue and global market share of Ivosidenib from 2019 to 2024.
Chapter 3, the Ivosidenib competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ivosidenib breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Ivosidenib market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ivosidenib.
Chapter 14 and 15, to describe Ivosidenib sales channel, distributors, customers, research findings and conclusion.
Ivosidenib is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer.
Ivosidenib's market driver is its efficacy in treating relapsed or refractory acute myeloid leukemia (AML) with IDH1 mutations. It inhibits the mutated IDH1 enzyme, leading to remission. The niche target population and limited treatment options contribute to its growth. However, challenges include potential side effects, the need for genetic testing to identify eligible patients, and competition from other AML therapies. Despite challenges, Ivosidenib's promising results and ongoing research in AML with IDH1 mutations present opportunities for market expansion.
The Global Info Research report includes an overview of the development of the Ivosidenib industry chain, the market status of Hospital (60 Tablets, 30 Tablets), Pharmacy (60 Tablets, 30 Tablets), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Ivosidenib.
Regionally, the report analyzes the Ivosidenib markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Ivosidenib market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Ivosidenib market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Ivosidenib industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., 60 Tablets, 30 Tablets).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Ivosidenib market.
Regional Analysis: The report involves examining the Ivosidenib market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Ivosidenib market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Ivosidenib:
Company Analysis: Report covers individual Ivosidenib manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Ivosidenib This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Pharmacy).
Technology Analysis: Report covers specific technologies relevant to Ivosidenib. It assesses the current state, advancements, and potential future developments in Ivosidenib areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Ivosidenib market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Ivosidenib market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- 60 Tablets
- 30 Tablets
- Hospital
- Pharmacy
- Servier Pharmaceuticals
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Ivosidenib product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ivosidenib, with price, sales, revenue and global market share of Ivosidenib from 2019 to 2024.
Chapter 3, the Ivosidenib competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ivosidenib breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Ivosidenib market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ivosidenib.
Chapter 14 and 15, to describe Ivosidenib sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Ivosidenib
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Ivosidenib Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 60 Tablets
1.3.3 30 Tablets
1.4 Market Analysis by Application
1.4.1 Overview: Global Ivosidenib Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Pharmacy
1.5 Global Ivosidenib Market Size & Forecast
1.5.1 Global Ivosidenib Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Ivosidenib Sales Quantity (2019-2030)
1.5.3 Global Ivosidenib Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Servier Pharmaceuticals
2.1.1 Servier Pharmaceuticals Details
2.1.2 Servier Pharmaceuticals Major Business
2.1.3 Servier Pharmaceuticals Ivosidenib Product and Services
2.1.4 Servier Pharmaceuticals Ivosidenib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Servier Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IVOSIDENIB BY MANUFACTURER
3.1 Global Ivosidenib Sales Quantity by Manufacturer (2019-2024)
3.2 Global Ivosidenib Revenue by Manufacturer (2019-2024)
3.3 Global Ivosidenib Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Ivosidenib by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Ivosidenib Manufacturer Market Share in 2023
3.4.2 Top 6 Ivosidenib Manufacturer Market Share in 2023
3.5 Ivosidenib Market: Overall Company Footprint Analysis
3.5.1 Ivosidenib Market: Region Footprint
3.5.2 Ivosidenib Market: Company Product Type Footprint
3.5.3 Ivosidenib Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Ivosidenib Market Size by Region
4.1.1 Global Ivosidenib Sales Quantity by Region (2019-2030)
4.1.2 Global Ivosidenib Consumption Value by Region (2019-2030)
4.1.3 Global Ivosidenib Average Price by Region (2019-2030)
4.2 North America Ivosidenib Consumption Value (2019-2030)
4.3 Europe Ivosidenib Consumption Value (2019-2030)
4.4 Asia-Pacific Ivosidenib Consumption Value (2019-2030)
4.5 South America Ivosidenib Consumption Value (2019-2030)
4.6 Middle East and Africa Ivosidenib Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Ivosidenib Sales Quantity by Type (2019-2030)
5.2 Global Ivosidenib Consumption Value by Type (2019-2030)
5.3 Global Ivosidenib Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Ivosidenib Sales Quantity by Application (2019-2030)
6.2 Global Ivosidenib Consumption Value by Application (2019-2030)
6.3 Global Ivosidenib Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Ivosidenib Sales Quantity by Type (2019-2030)
7.2 North America Ivosidenib Sales Quantity by Application (2019-2030)
7.3 North America Ivosidenib Market Size by Country
7.3.1 North America Ivosidenib Sales Quantity by Country (2019-2030)
7.3.2 North America Ivosidenib Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Ivosidenib Sales Quantity by Type (2019-2030)
8.2 Europe Ivosidenib Sales Quantity by Application (2019-2030)
8.3 Europe Ivosidenib Market Size by Country
8.3.1 Europe Ivosidenib Sales Quantity by Country (2019-2030)
8.3.2 Europe Ivosidenib Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Ivosidenib Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Ivosidenib Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Ivosidenib Market Size by Region
9.3.1 Asia-Pacific Ivosidenib Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Ivosidenib Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Ivosidenib Sales Quantity by Type (2019-2030)
10.2 South America Ivosidenib Sales Quantity by Application (2019-2030)
10.3 South America Ivosidenib Market Size by Country
10.3.1 South America Ivosidenib Sales Quantity by Country (2019-2030)
10.3.2 South America Ivosidenib Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Ivosidenib Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Ivosidenib Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Ivosidenib Market Size by Country
11.3.1 Middle East & Africa Ivosidenib Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Ivosidenib Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Ivosidenib Market Drivers
12.2 Ivosidenib Market Restraints
12.3 Ivosidenib Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Ivosidenib and Key Manufacturers
13.2 Manufacturing Costs Percentage of Ivosidenib
13.3 Ivosidenib Production Process
13.4 Ivosidenib Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Ivosidenib Typical Distributors
14.3 Ivosidenib Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Ivosidenib
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Ivosidenib Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 60 Tablets
1.3.3 30 Tablets
1.4 Market Analysis by Application
1.4.1 Overview: Global Ivosidenib Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Pharmacy
1.5 Global Ivosidenib Market Size & Forecast
1.5.1 Global Ivosidenib Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Ivosidenib Sales Quantity (2019-2030)
1.5.3 Global Ivosidenib Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Servier Pharmaceuticals
2.1.1 Servier Pharmaceuticals Details
2.1.2 Servier Pharmaceuticals Major Business
2.1.3 Servier Pharmaceuticals Ivosidenib Product and Services
2.1.4 Servier Pharmaceuticals Ivosidenib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Servier Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IVOSIDENIB BY MANUFACTURER
3.1 Global Ivosidenib Sales Quantity by Manufacturer (2019-2024)
3.2 Global Ivosidenib Revenue by Manufacturer (2019-2024)
3.3 Global Ivosidenib Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Ivosidenib by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Ivosidenib Manufacturer Market Share in 2023
3.4.2 Top 6 Ivosidenib Manufacturer Market Share in 2023
3.5 Ivosidenib Market: Overall Company Footprint Analysis
3.5.1 Ivosidenib Market: Region Footprint
3.5.2 Ivosidenib Market: Company Product Type Footprint
3.5.3 Ivosidenib Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Ivosidenib Market Size by Region
4.1.1 Global Ivosidenib Sales Quantity by Region (2019-2030)
4.1.2 Global Ivosidenib Consumption Value by Region (2019-2030)
4.1.3 Global Ivosidenib Average Price by Region (2019-2030)
4.2 North America Ivosidenib Consumption Value (2019-2030)
4.3 Europe Ivosidenib Consumption Value (2019-2030)
4.4 Asia-Pacific Ivosidenib Consumption Value (2019-2030)
4.5 South America Ivosidenib Consumption Value (2019-2030)
4.6 Middle East and Africa Ivosidenib Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Ivosidenib Sales Quantity by Type (2019-2030)
5.2 Global Ivosidenib Consumption Value by Type (2019-2030)
5.3 Global Ivosidenib Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Ivosidenib Sales Quantity by Application (2019-2030)
6.2 Global Ivosidenib Consumption Value by Application (2019-2030)
6.3 Global Ivosidenib Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Ivosidenib Sales Quantity by Type (2019-2030)
7.2 North America Ivosidenib Sales Quantity by Application (2019-2030)
7.3 North America Ivosidenib Market Size by Country
7.3.1 North America Ivosidenib Sales Quantity by Country (2019-2030)
7.3.2 North America Ivosidenib Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Ivosidenib Sales Quantity by Type (2019-2030)
8.2 Europe Ivosidenib Sales Quantity by Application (2019-2030)
8.3 Europe Ivosidenib Market Size by Country
8.3.1 Europe Ivosidenib Sales Quantity by Country (2019-2030)
8.3.2 Europe Ivosidenib Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Ivosidenib Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Ivosidenib Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Ivosidenib Market Size by Region
9.3.1 Asia-Pacific Ivosidenib Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Ivosidenib Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Ivosidenib Sales Quantity by Type (2019-2030)
10.2 South America Ivosidenib Sales Quantity by Application (2019-2030)
10.3 South America Ivosidenib Market Size by Country
10.3.1 South America Ivosidenib Sales Quantity by Country (2019-2030)
10.3.2 South America Ivosidenib Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Ivosidenib Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Ivosidenib Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Ivosidenib Market Size by Country
11.3.1 Middle East & Africa Ivosidenib Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Ivosidenib Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Ivosidenib Market Drivers
12.2 Ivosidenib Market Restraints
12.3 Ivosidenib Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Ivosidenib and Key Manufacturers
13.2 Manufacturing Costs Percentage of Ivosidenib
13.3 Ivosidenib Production Process
13.4 Ivosidenib Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Ivosidenib Typical Distributors
14.3 Ivosidenib Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Ivosidenib Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Ivosidenib Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Servier Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Servier Pharmaceuticals Major Business
Table 5. Servier Pharmaceuticals Ivosidenib Product and Services
Table 6. Servier Pharmaceuticals Ivosidenib Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Servier Pharmaceuticals Recent Developments/Updates
Table 8. Global Ivosidenib Sales Quantity by Manufacturer (2019-2024) & (Units)
Table 9. Global Ivosidenib Revenue by Manufacturer (2019-2024) & (USD Million)
Table 10. Global Ivosidenib Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 11. Market Position of Manufacturers in Ivosidenib, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 12. Head Office and Ivosidenib Production Site of Key Manufacturer
Table 13. Ivosidenib Market: Company Product Type Footprint
Table 14. Ivosidenib Market: Company Product Application Footprint
Table 15. Ivosidenib New Market Entrants and Barriers to Market Entry
Table 16. Ivosidenib Mergers, Acquisition, Agreements, and Collaborations
Table 17. Global Ivosidenib Sales Quantity by Region (2019-2024) & (Units)
Table 18. Global Ivosidenib Sales Quantity by Region (2025-2030) & (Units)
Table 19. Global Ivosidenib Consumption Value by Region (2019-2024) & (USD Million)
Table 20. Global Ivosidenib Consumption Value by Region (2025-2030) & (USD Million)
Table 21. Global Ivosidenib Average Price by Region (2019-2024) & (USD/Unit)
Table 22. Global Ivosidenib Average Price by Region (2025-2030) & (USD/Unit)
Table 23. Global Ivosidenib Sales Quantity by Type (2019-2024) & (Units)
Table 24. Global Ivosidenib Sales Quantity by Type (2025-2030) & (Units)
Table 25. Global Ivosidenib Consumption Value by Type (2019-2024) & (USD Million)
Table 26. Global Ivosidenib Consumption Value by Type (2025-2030) & (USD Million)
Table 27. Global Ivosidenib Average Price by Type (2019-2024) & (USD/Unit)
Table 28. Global Ivosidenib Average Price by Type (2025-2030) & (USD/Unit)
Table 29. Global Ivosidenib Sales Quantity by Application (2019-2024) & (Units)
Table 30. Global Ivosidenib Sales Quantity by Application (2025-2030) & (Units)
Table 31. Global Ivosidenib Consumption Value by Application (2019-2024) & (USD Million)
Table 32. Global Ivosidenib Consumption Value by Application (2025-2030) & (USD Million)
Table 33. Global Ivosidenib Average Price by Application (2019-2024) & (USD/Unit)
Table 34. Global Ivosidenib Average Price by Application (2025-2030) & (USD/Unit)
Table 35. North America Ivosidenib Sales Quantity by Type (2019-2024) & (Units)
Table 36. North America Ivosidenib Sales Quantity by Type (2025-2030) & (Units)
Table 37. North America Ivosidenib Sales Quantity by Application (2019-2024) & (Units)
Table 38. North America Ivosidenib Sales Quantity by Application (2025-2030) & (Units)
Table 39. North America Ivosidenib Sales Quantity by Country (2019-2024) & (Units)
Table 40. North America Ivosidenib Sales Quantity by Country (2025-2030) & (Units)
Table 41. North America Ivosidenib Consumption Value by Country (2019-2024) & (USD Million)
Table 42. North America Ivosidenib Consumption Value by Country (2025-2030) & (USD Million)
Table 43. Europe Ivosidenib Sales Quantity by Type (2019-2024) & (Units)
Table 44. Europe Ivosidenib Sales Quantity by Type (2025-2030) & (Units)
Table 45. Europe Ivosidenib Sales Quantity by Application (2019-2024) & (Units)
Table 46. Europe Ivosidenib Sales Quantity by Application (2025-2030) & (Units)
Table 47. Europe Ivosidenib Sales Quantity by Country (2019-2024) & (Units)
Table 48. Europe Ivosidenib Sales Quantity by Country (2025-2030) & (Units)
Table 49. Europe Ivosidenib Consumption Value by Country (2019-2024) & (USD Million)
Table 50. Europe Ivosidenib Consumption Value by Country (2025-2030) & (USD Million)
Table 51. Asia-Pacific Ivosidenib Sales Quantity by Type (2019-2024) & (Units)
Table 52. Asia-Pacific Ivosidenib Sales Quantity by Type (2025-2030) & (Units)
Table 53. Asia-Pacific Ivosidenib Sales Quantity by Application (2019-2024) & (Units)
Table 54. Asia-Pacific Ivosidenib Sales Quantity by Application (2025-2030) & (Units)
Table 55. Asia-Pacific Ivosidenib Sales Quantity by Region (2019-2024) & (Units)
Table 56. Asia-Pacific Ivosidenib Sales Quantity by Region (2025-2030) & (Units)
Table 57. Asia-Pacific Ivosidenib Consumption Value by Region (2019-2024) & (USD Million)
Table 58. Asia-Pacific Ivosidenib Consumption Value by Region (2025-2030) & (USD Million)
Table 59. South America Ivosidenib Sales Quantity by Type (2019-2024) & (Units)
Table 60. South America Ivosidenib Sales Quantity by Type (2025-2030) & (Units)
Table 61. South America Ivosidenib Sales Quantity by Application (2019-2024) & (Units)
Table 62. South America Ivosidenib Sales Quantity by Application (2025-2030) & (Units)
Table 63. South America Ivosidenib Sales Quantity by Country (2019-2024) & (Units)
Table 64. South America Ivosidenib Sales Quantity by Country (2025-2030) & (Units)
Table 65. South America Ivosidenib Consumption Value by Country (2019-2024) & (USD Million)
Table 66. South America Ivosidenib Consumption Value by Country (2025-2030) & (USD Million)
Table 67. Middle East & Africa Ivosidenib Sales Quantity by Type (2019-2024) & (Units)
Table 68. Middle East & Africa Ivosidenib Sales Quantity by Type (2025-2030) & (Units)
Table 69. Middle East & Africa Ivosidenib Sales Quantity by Application (2019-2024) & (Units)
Table 70. Middle East & Africa Ivosidenib Sales Quantity by Application (2025-2030) & (Units)
Table 71. Middle East & Africa Ivosidenib Sales Quantity by Region (2019-2024) & (Units)
Table 72. Middle East & Africa Ivosidenib Sales Quantity by Region (2025-2030) & (Units)
Table 73. Middle East & Africa Ivosidenib Consumption Value by Region (2019-2024) & (USD Million)
Table 74. Middle East & Africa Ivosidenib Consumption Value by Region (2025-2030) & (USD Million)
Table 75. Ivosidenib Raw Material
Table 76. Key Manufacturers of Ivosidenib Raw Materials
Table 77. Ivosidenib Typical Distributors
Table 78. Ivosidenib Typical Customers
Table 1. Global Ivosidenib Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Ivosidenib Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Servier Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Servier Pharmaceuticals Major Business
Table 5. Servier Pharmaceuticals Ivosidenib Product and Services
Table 6. Servier Pharmaceuticals Ivosidenib Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Servier Pharmaceuticals Recent Developments/Updates
Table 8. Global Ivosidenib Sales Quantity by Manufacturer (2019-2024) & (Units)
Table 9. Global Ivosidenib Revenue by Manufacturer (2019-2024) & (USD Million)
Table 10. Global Ivosidenib Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 11. Market Position of Manufacturers in Ivosidenib, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 12. Head Office and Ivosidenib Production Site of Key Manufacturer
Table 13. Ivosidenib Market: Company Product Type Footprint
Table 14. Ivosidenib Market: Company Product Application Footprint
Table 15. Ivosidenib New Market Entrants and Barriers to Market Entry
Table 16. Ivosidenib Mergers, Acquisition, Agreements, and Collaborations
Table 17. Global Ivosidenib Sales Quantity by Region (2019-2024) & (Units)
Table 18. Global Ivosidenib Sales Quantity by Region (2025-2030) & (Units)
Table 19. Global Ivosidenib Consumption Value by Region (2019-2024) & (USD Million)
Table 20. Global Ivosidenib Consumption Value by Region (2025-2030) & (USD Million)
Table 21. Global Ivosidenib Average Price by Region (2019-2024) & (USD/Unit)
Table 22. Global Ivosidenib Average Price by Region (2025-2030) & (USD/Unit)
Table 23. Global Ivosidenib Sales Quantity by Type (2019-2024) & (Units)
Table 24. Global Ivosidenib Sales Quantity by Type (2025-2030) & (Units)
Table 25. Global Ivosidenib Consumption Value by Type (2019-2024) & (USD Million)
Table 26. Global Ivosidenib Consumption Value by Type (2025-2030) & (USD Million)
Table 27. Global Ivosidenib Average Price by Type (2019-2024) & (USD/Unit)
Table 28. Global Ivosidenib Average Price by Type (2025-2030) & (USD/Unit)
Table 29. Global Ivosidenib Sales Quantity by Application (2019-2024) & (Units)
Table 30. Global Ivosidenib Sales Quantity by Application (2025-2030) & (Units)
Table 31. Global Ivosidenib Consumption Value by Application (2019-2024) & (USD Million)
Table 32. Global Ivosidenib Consumption Value by Application (2025-2030) & (USD Million)
Table 33. Global Ivosidenib Average Price by Application (2019-2024) & (USD/Unit)
Table 34. Global Ivosidenib Average Price by Application (2025-2030) & (USD/Unit)
Table 35. North America Ivosidenib Sales Quantity by Type (2019-2024) & (Units)
Table 36. North America Ivosidenib Sales Quantity by Type (2025-2030) & (Units)
Table 37. North America Ivosidenib Sales Quantity by Application (2019-2024) & (Units)
Table 38. North America Ivosidenib Sales Quantity by Application (2025-2030) & (Units)
Table 39. North America Ivosidenib Sales Quantity by Country (2019-2024) & (Units)
Table 40. North America Ivosidenib Sales Quantity by Country (2025-2030) & (Units)
Table 41. North America Ivosidenib Consumption Value by Country (2019-2024) & (USD Million)
Table 42. North America Ivosidenib Consumption Value by Country (2025-2030) & (USD Million)
Table 43. Europe Ivosidenib Sales Quantity by Type (2019-2024) & (Units)
Table 44. Europe Ivosidenib Sales Quantity by Type (2025-2030) & (Units)
Table 45. Europe Ivosidenib Sales Quantity by Application (2019-2024) & (Units)
Table 46. Europe Ivosidenib Sales Quantity by Application (2025-2030) & (Units)
Table 47. Europe Ivosidenib Sales Quantity by Country (2019-2024) & (Units)
Table 48. Europe Ivosidenib Sales Quantity by Country (2025-2030) & (Units)
Table 49. Europe Ivosidenib Consumption Value by Country (2019-2024) & (USD Million)
Table 50. Europe Ivosidenib Consumption Value by Country (2025-2030) & (USD Million)
Table 51. Asia-Pacific Ivosidenib Sales Quantity by Type (2019-2024) & (Units)
Table 52. Asia-Pacific Ivosidenib Sales Quantity by Type (2025-2030) & (Units)
Table 53. Asia-Pacific Ivosidenib Sales Quantity by Application (2019-2024) & (Units)
Table 54. Asia-Pacific Ivosidenib Sales Quantity by Application (2025-2030) & (Units)
Table 55. Asia-Pacific Ivosidenib Sales Quantity by Region (2019-2024) & (Units)
Table 56. Asia-Pacific Ivosidenib Sales Quantity by Region (2025-2030) & (Units)
Table 57. Asia-Pacific Ivosidenib Consumption Value by Region (2019-2024) & (USD Million)
Table 58. Asia-Pacific Ivosidenib Consumption Value by Region (2025-2030) & (USD Million)
Table 59. South America Ivosidenib Sales Quantity by Type (2019-2024) & (Units)
Table 60. South America Ivosidenib Sales Quantity by Type (2025-2030) & (Units)
Table 61. South America Ivosidenib Sales Quantity by Application (2019-2024) & (Units)
Table 62. South America Ivosidenib Sales Quantity by Application (2025-2030) & (Units)
Table 63. South America Ivosidenib Sales Quantity by Country (2019-2024) & (Units)
Table 64. South America Ivosidenib Sales Quantity by Country (2025-2030) & (Units)
Table 65. South America Ivosidenib Consumption Value by Country (2019-2024) & (USD Million)
Table 66. South America Ivosidenib Consumption Value by Country (2025-2030) & (USD Million)
Table 67. Middle East & Africa Ivosidenib Sales Quantity by Type (2019-2024) & (Units)
Table 68. Middle East & Africa Ivosidenib Sales Quantity by Type (2025-2030) & (Units)
Table 69. Middle East & Africa Ivosidenib Sales Quantity by Application (2019-2024) & (Units)
Table 70. Middle East & Africa Ivosidenib Sales Quantity by Application (2025-2030) & (Units)
Table 71. Middle East & Africa Ivosidenib Sales Quantity by Region (2019-2024) & (Units)
Table 72. Middle East & Africa Ivosidenib Sales Quantity by Region (2025-2030) & (Units)
Table 73. Middle East & Africa Ivosidenib Consumption Value by Region (2019-2024) & (USD Million)
Table 74. Middle East & Africa Ivosidenib Consumption Value by Region (2025-2030) & (USD Million)
Table 75. Ivosidenib Raw Material
Table 76. Key Manufacturers of Ivosidenib Raw Materials
Table 77. Ivosidenib Typical Distributors
Table 78. Ivosidenib Typical Customers
LIST OF FIGURES
Figure 1. Ivosidenib Picture
Figure 2. Global Ivosidenib Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Ivosidenib Consumption Value Market Share by Type in 2023
Figure 4. 60 Tablets Examples
Figure 5. 30 Tablets Examples
Figure 6. Global Ivosidenib Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Ivosidenib Consumption Value Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. Pharmacy Examples
Figure 10. Global Ivosidenib Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Ivosidenib Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Ivosidenib Sales Quantity (2019-2030) & (Units)
Figure 13. Global Ivosidenib Average Price (2019-2030) & (USD/Unit)
Figure 14. Global Ivosidenib Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Ivosidenib Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Ivosidenib by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Ivosidenib Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Ivosidenib Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Ivosidenib Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Ivosidenib Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Ivosidenib Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Ivosidenib Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Ivosidenib Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Ivosidenib Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Ivosidenib Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Ivosidenib Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Ivosidenib Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Ivosidenib Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global Ivosidenib Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Ivosidenib Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Ivosidenib Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America Ivosidenib Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Ivosidenib Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Ivosidenib Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Ivosidenib Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Ivosidenib Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Ivosidenib Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Ivosidenib Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Ivosidenib Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Ivosidenib Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Ivosidenib Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Ivosidenib Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Ivosidenib Consumption Value Market Share by Region (2019-2030)
Figure 52. China Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Ivosidenib Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Ivosidenib Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Ivosidenib Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Ivosidenib Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Ivosidenib Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Ivosidenib Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Ivosidenib Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Ivosidenib Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Ivosidenib Market Drivers
Figure 73. Ivosidenib Market Restraints
Figure 74. Ivosidenib Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Ivosidenib in 2023
Figure 77. Manufacturing Process Analysis of Ivosidenib
Figure 78. Ivosidenib Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Ivosidenib Picture
Figure 2. Global Ivosidenib Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Ivosidenib Consumption Value Market Share by Type in 2023
Figure 4. 60 Tablets Examples
Figure 5. 30 Tablets Examples
Figure 6. Global Ivosidenib Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Ivosidenib Consumption Value Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. Pharmacy Examples
Figure 10. Global Ivosidenib Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Ivosidenib Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Ivosidenib Sales Quantity (2019-2030) & (Units)
Figure 13. Global Ivosidenib Average Price (2019-2030) & (USD/Unit)
Figure 14. Global Ivosidenib Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Ivosidenib Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Ivosidenib by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Ivosidenib Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Ivosidenib Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Ivosidenib Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Ivosidenib Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Ivosidenib Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Ivosidenib Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Ivosidenib Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Ivosidenib Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Ivosidenib Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Ivosidenib Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Ivosidenib Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Ivosidenib Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global Ivosidenib Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Ivosidenib Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Ivosidenib Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America Ivosidenib Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Ivosidenib Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Ivosidenib Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Ivosidenib Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Ivosidenib Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Ivosidenib Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Ivosidenib Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Ivosidenib Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Ivosidenib Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Ivosidenib Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Ivosidenib Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Ivosidenib Consumption Value Market Share by Region (2019-2030)
Figure 52. China Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Ivosidenib Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Ivosidenib Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Ivosidenib Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Ivosidenib Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Ivosidenib Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Ivosidenib Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Ivosidenib Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Ivosidenib Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Ivosidenib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Ivosidenib Market Drivers
Figure 73. Ivosidenib Market Restraints
Figure 74. Ivosidenib Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Ivosidenib in 2023
Figure 77. Manufacturing Process Analysis of Ivosidenib
Figure 78. Ivosidenib Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
More Publications
Global Trospium chloride Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024
US$ 3,480.00
January 2019
121 pages
Global Topical Fluoride Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
US$ 3,480.00
July 2024
141 pages
Global Capsule Filter Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
US$ 3,480.00
July 2018
154 pages
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Paclitaxel Market 2018 Forecast to 2023
US$ 4,880.00
March 2018
102 pages
Global Pharmerging Market 2025 by Company, Regions, Type and Application, Forecast to 2031
US$ 3,480.00
February 2025
146 pages
